Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.
暂无分享,去创建一个
[1] S. Jyonouchi,et al. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy. , 2001, Thyroid : official journal of the American Thyroid Association.
[2] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[3] M. Prummel,et al. Both Th1‐ and Th2‐derived cytokines in serum are elevated in Graves' ophthalmopathy , 2000, Clinical and experimental immunology.
[4] E. Roti,et al. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. , 2000, European journal of endocrinology.
[5] T. Bednarczuk,et al. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. , 2000, The Journal of clinical endocrinology and metabolism.
[6] R. Bahn,et al. Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy. , 2000, The Journal of clinical endocrinology and metabolism.
[7] Förster,et al. Analysis of orbital T cells in thyroid‐associated ophthalmopathy , 1998, Clinical and experimental immunology.
[8] P. Fells,et al. Analysis of extraocular muscle‐infiltrating T cells in thyroid‐associated ophthalmopathy (TAO) , 1997, Clinical and experimental immunology.
[9] C. Balázs,et al. High circulating IL-6 level in Graves' ophthalmopathy. , 1997, Autoimmunity.
[10] R. Bahn,et al. Cytokines in the evolution of Graves' ophthalmopathy. , 1997, Autoimmunity.
[11] T. Kuroki,et al. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. , 1995, The Journal of clinical endocrinology and metabolism.
[12] C. Dinarello,et al. The interleuldn-1 family: 10 years of discovery’ , 2004 .
[13] H. Dienes,et al. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. , 1994, Clinical immunology and immunopathology.
[14] W. Holter,et al. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. , 1994, The Journal of clinical investigation.
[15] M. Prummel,et al. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. , 1994, The Journal of clinical endocrinology and metabolism.
[16] A. Heufelder,et al. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. , 1994, Investigative ophthalmology & visual science.
[17] C. Marcocci,et al. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. , 1993, The Journal of clinical endocrinology and metabolism.
[18] Andreas Radbruch,et al. Regulation of T helper cell cytokine expression: functional dichotomy of antigen‐presenting cells , 1993, European journal of immunology.
[19] A. Heufelder,et al. Detection and localization of cytokine immunoreactivity in retro‐ocular connective tissue in Graves' opthalmopathy , 1993, European journal of clinical investigation.
[20] M P Bevilacqua,et al. Endothelial-leukocyte adhesion molecules. , 1993, Annual review of immunology.
[21] K. Matsushima,et al. Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.
[22] K. Matsushima,et al. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. , 1989, Cytokine.
[23] P. Fells,et al. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. , 1989, Clinical and experimental immunology.
[24] C. Dinarello. Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.
[25] E. Appella,et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.
[26] T. Tötterman,et al. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. , 1987, The New England journal of medicine.
[27] Michael Loran Dustin,et al. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.
[28] S. Durum,et al. Interleukin 1: an immunological perspective. , 1985, Annual review of immunology.